Imputed gene expression risk scores: a functionally informed component of polygenic risk

Abstract

Background Integration of functional genomic annotations when estimating polygenic risk scores (PRS) can provide insight into aetiology and improve risk prediction. This study explores the predictive utility of gene expression risk scores (GeRS), calculated using imputed gene expression and transcriptome-wide association study (TWAS) results. Methods The predictive utility of GeRS was evaluated using 12 neuropsychiatric and anthropometric outcomes measured in two target samples: UK Biobank and the Twins Early Development Study (TEDS). GeRS were calculated based on imputed gene expression levels and TWAS results, using 53 gene expression-genotype panels, termed SNP-weight sets, capturing expression across a range of tissues. We compare the predictive utility of elastic net models containing GeRS within and across SNP-weight sets, and models containing both GeRS and PRS. We estimate the proportion of SNP-based heritability attributable to cis-regulated gene expression. Results GeRS significantly predicted a range of outcomes, with elastic net models combining GeRS across SNP-weight sets improving prediction. GeRS were less predictive than PRS, but models combining GeRS and PRS improved prediction for several outcomes, with relative improvements ranging from 0.3% for Height (p = 0.023) to 4% for Rheumatoid Arthritis (p = 5.9 × 10−8). The proportion of SNP-based heritability attributable to cis-regulated expression was modest for most outcomes, even when restricting GeRS to colocalised genes. Conclusion GeRS represent a component of PRS and could be useful for functional stratification of genetic risk. Only in specific circumstances can GeRS substantially improve prediction over PRS alone. Future research considering functional genomic annotations when estimating genetic risk is warranted.

Metabolomic Investigation of Major Depressive Disorder Identifies a Potentially Causal Association With Polyunsaturated Fatty Acids

“…There have been several recent studies investigating the links between genetic risk for MDD and molecular phenotypes, including DNA methylation (14,15), messenger RNA (mRNA) levels (16,17), and protein markers (18,19). Metabolomics considers the role of circulating metabolites (20), including lipids, amino acids, and other small molecules that have been implicated in a range of disorders and some hypothesis-driven studies of MDD (21,22).…”

Polygenic transcriptome risk scores (PTRS) can improve portability of polygenic risk scores across ancestries

“…Therefore, we propose the polygenic transcriptomic risk score (PTRS) as a gene-based complement to the PRS that can help improve portability across human ancestry groups. We recognize that PTRS alone does not outperform the state of the art PRS [ 12 ]. However, integrating PTRS to PRS construction has many desirable properties.…”

Harnessing Transcriptomic Signals for Amyotrophic Lateral Sclerosis to Identify Novel Drugs and Enhance Risk Prediction

“…We removed TWAS associations if they had a high Pearson correlation with a lead gene (r > 0.95). This clumping and thresholding approach was carried out using the IFRisk script (https://github.com/opain/Inferred-functional-risk-scoring) and is consistent with a previous study generating TWAS-based risk scores (Pain et al, 2021).…”